Decreased body mass index is associated with poor prognosis in patients with multiple myeloma

Annals of Hematology

Volumn 93, Issue 5, 2014, Pages 835-840

  Jung, Sung Hoon ^a   Yang, Deok Hwan ^a   Ahn, Jae Sook ^a   Lee, Seung Shin ^a   Ahn, Seo Yeon ^a   Kim, Yeo Kyeoung ^a   Kim, Hyeoung Joon ^a   Lee, Je Jung ^a,b  

^a Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Body mass index; Multiple myeloma; Prognosis; Survival

Indexed keywords

BORTEZOMIB; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; LENALIDOMIDE; MELPHALAN; PREDNISOLONE; THALIDOMIDE; VINCRISTINE;

AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BODY MASS; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; WEIGHT LOSS;

EID: 84898849051     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1977-9     Document Type: Article

References (30)

1. Kyle RA, Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351:1860-1873
2. Becker N (2011) Epidemiology of multiple myeloma. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 183:25-35
3. Kristinsson SY, Landgren O, Dickman PW et al (2007) Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 25:1993-1999
4. Brenner H, Gondos A, Pulte D (2008) Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 111:2521-2526
5. Dewys WD, Begg C, Lavin PT et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491-497
6. Obesity rates in the OECD and beyond (2012) www.oecd.org/health/ fitnotfat. Accessed 4 Dec 2013
7. Tee ES (2002) Obesity in Asia: prevalence and issues in assessment methodologies. Asia Pac J Clin Nutr 11(Suppl 8):S694-S701
8. WHO Expert Consultation (2004) Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-163
9. Consultation WHOE (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-163
10. Zheng W, McLerran DF, Rolland B et al (2011) Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 364:719-729
11. The Korean Society for the Study of Obesity (2009) Guideline of obesity in Korean http://kosso.or.kr. Accessed 5 Sept 2011
12. Waalkes S, Merseburger AS, Kramer MW et al (2010) Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control 21:1905-1910
13. Yang R, Cheung MC, Pedroso FE et al (2011) Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res 170:e75-e83
14. Carson KR, Bartlett NL, McDonald JR et al (2012) Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma. J Clin Oncol 30:3217-3222
15. Parr CL, Batty GD, Lam TH et al (2010) Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. Lancet Oncol 11:741-752
16. Bozzetti F, Group SW (2009) Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 17:279-284
17. Skipworth RJ, Stewart GD, Dejong CH et al (2007) Pathophysiology of cancer cachexia: much more than host-tumour interaction? Clin Nutr 26:667-676
18. Martin L, Birdsell L, Macdonald N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539-1547
19. Moses AW, Slater C, Preston T et al (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90:996-1002
20. Bachmann J, Heiligensetzer M, Krakowski-Roosen H et al (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12:1193-1201
21. Miya T, Goya T, Yanagida O et al (1998) The influence of relative body weight on toxicity of combination chemotherapy with cisplatin and etoposide. Cancer Chemother Pharmacol 42:386-390
22. Kim WY, Woo SU, Seo JH et al (2011) Toxicities, dose reduction and delay of docetaxel and paclitaxel chemotherapy in breast cancer without distant metastases. J Cancer Res Ther 7:412-415
23. Bosly A, Bron D, Van Hoof A et al (2008) Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP. Ann Hematol 87:277-283
24. Blade J, Fernandez-Llama P, Bosch F et al (1998) Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 158:1889-1893
25. Knudsen LM, Hjorth M, Hippe E (2000) Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol 65:175-181
26. Sakhuja V, Jha V, Varma S et al (2000) Renal involvement in multiple myeloma: a 10-year study. Ren Fail 22:465-477
27. Phung DT, Wang Z (2013) Risk of pneumonia in relation to body mass index in Australian Aboriginal people. Epidemiol Infect 141(12):2497-2502
28. Almirall J, Bolibar I, Balanzo X et al (1999) Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 13:349-355
29. Munshi NC, Anderson KC, Bergsagel PL et al (2011) Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2. Blood 117:4696-4700
30. Zhou Y, Barlogie B, Shaughnessy JD Jr (2009) The molecular characterization and clinical management of multiple myeloma in the post-genome era. Leukemia 23:1941-1956